A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

Molecular Psychiatry

Volumn 15, Issue 11, 2010, Pages 1053-1066

  Arcos Burgos, M ^a   Jain, M ^a   Acosta, M T ^a   Shively, S ^a,b   Stanescu, H ^a   Wallis, D ^a   Domene S ^a   Velez J I ^a   Karkera, J D ^a   Balog, J ^a   Berg, K ^a   Kleta, R ^a   Gahl, W A ^a   Roessler, E ^a   Long, R ^a   Lie, J ^b   Pineda, D ^c   Londoo A C ^c   Palacio, J D ^c   Arbelaez, A ^c   Lopera, F ^c   Elia, J ^d   Hakonarson, H ^d   Johansson, S ^e   Knappskog, P M ^e   Haavik, J ^e   Ribases, M ^f   Cormand, B ^g   Bayes, M ^h   Casas, M ^f,i   Ramos Quiroga, J A ^f,i   Hervas, A ^j   Maher, B S ^k   Faraone, S V ^l   Seitz, C ^m   Freitag, C M ^m   Palmason, H ⁿ   Meyer, J ⁿ   Romanos, M ^o   Walitza, S ^o   Hemminger, U ^o   Warnke, A ^o   Romanos, J ^o   Renner, T ^o   Jacob, C ^o   Lesch, K P ^o   Swanson, J ^p   Vortmeyer, A ^b   Bailey Wilson, J E ^a   Castellanos, F X ^q   Muenke, M ^a   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e UNIVERSITY OF BERGEN   (Norway)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^j HOSPITAL MÚTUA DE TERRASSA   (Spain)

^k VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^l State University of New York Upstate Medical University: College of Medicine   (United States)

^m SAARLAND UNIVERSITY   (Germany)

ⁿ UNIVERSITY OF TRIER   (Germany)

^o UNIVERSITY OF WÜRZBURG   (Germany)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q NEW YORK UNIVERSITY   (United States)

more..

Author keywords

ADHD; complex trait; gene; genetics; latrophilin; LPHN3

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ATTENTION DEFICIT DISORDER; CHILD; FAMILY HISTORY; GENE; GENE FUNCTION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATROPHILIN 3 GENE; MAJOR CLINICAL STUDY; PHENOTYPE; POPULATION GENETICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCHOOL CHILD;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CHROMOSOME MAPPING; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; POLYMORPHISM, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE;

EID: 77954902187     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.6     Document Type: Review

References (59)

1. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237-248.
2. Faraone SV, Biederman J, Mennin D, Gershon J, Tsuang MT. A prospective four-year follow-up study of children at risk for ADHD: psychiatric, neuropsychological, and psychosocial outcome. J Am Acad Child Adolesc Psychiatry 1996; 35: 1449-1459.
3. Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 2007; 32: 711-727.
4. Palacio JD, Castellanos FX, Pineda DA, Lopera F, Arcos-Burgos M, Quiroz YT et al. Attention-deficit/hyperactivity disorder and comorbidities in 18 Paisa Colombian multigenerational families. J Am Acad Child Adolesc Psychiatry 2004; 43: 1506-1515.
5. Biederman J, Petty CR, Wilens TE, Fraire MG, Purcell CA, Mick E et al. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders. Am J Psychiatry 2008; 165: 107-115.
6. Cook Jr EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
7. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, King N, Kennedy JL et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124.
8. Thapar A, Langley K, Owen MJ, O'Donovan MC. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med 2007; 37: 1681-1692.
9. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006; 15: 2276-2284.
10. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
11. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1337-1344.
12. Maher BS, Riley BP, Kendler KS. Psychiatric genetics gets a boost. Nat Genet 2008; 40: 1042-1044.
13. McCarthy MI, Hirschhorn JN. Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 2008; 17: R156-R165.
14. Arcos-Burgos M, Castellanos FX, Lopera F, Pineda D, Palacio JD, Garcia M et al. Attention-deficit/hyperactivity disorder (ADHD): feasibility of linkage analysis in a genetic isolate using extended and multigenerational pedigrees. Clin Genet 2002; 61: 335-343.
15. Arcos-Burgos M, Castellanos FX, Pineda D, Lopera F, Palacio JD, Palacio LG et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 2004; 75: 998-1014.
16. Jain M, Palacio LG, Castellanos FX, Palacio JD, Pineda D, Restrepo MI et al. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci. Biol Psychiatry 2007; 61: 1329-1339.
17. Acosta MT, Castellanos FX, Bolton KL, Balog JZ, Eagen P, Nee L et al. Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions1. J Am Acad Child Adolesc Psychiatry 2008; 47: 797-807.
18. Elia J, Ambrosini P, Berrettini W. ADHD Characteristics: I. Concurrent Co-morbidity Patterns in Children & Adolescents. Child Adolesc Psychiatry Ment Health 2008; 2: 15.
19. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperac-tivity disorder. Mol Psychiatry 2005; 10: 1126-1132.
20. Johansson S, Halleland H, Halmoy A, Jacobsen KK, Landaas ET, Dramsdahl M et al. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1470-1475.
21. Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 2009; 14: 71-85.
22. Service S, DeYoung J, Karayiorgou M, Roos JL, Pretorious H, Bedoya G et al. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet 2006; 38: 556-560.
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
24. Wigginton JE, Abecasis GR. PEDSTATS: descriptive statistics graphics quality assessment for gene mapping data. Bioinformatics 2005; 21: 3445-3447.
25. Zollner S, Wen X, Hanchard NA, Herbert MA, Ober C, Pritchard JK. Evidence for extensive transmission distortion in the human genome. Am J Hum Genet 2004; 74: 62-72.
26. Durrant C, Zondervan KT, Cardon LR, Hunt S, Deloukas P, Morris AP. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. Am J Hum Genet 2004; 75: 35-43.
27. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39: 906-913.
28. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
29. Kazeem GR, Farrall M. Integrating case-control and TDT studies. Ann Hum Genet 2005; 69: 329-335.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
32. Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S et al. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 2003; 26: 218-221.
33. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectro-scopy study. Am J Psychiatry 2006; 163: 316-318.
34. Sun L, Jin Z, Zang YF, Zeng YW, Liu G, Li Y et al. Differences between attention-deficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study. Brain Dev 2005; 27: 340-344.
35. Yeo RA, Hill D, Campbell R, Vigil J, Brooks WM. Developmental instability and working memory ability in children: a magnetic resonance spectroscopy investigation. Dev Neuropsychol 2000; 17: 143-159.
36. Jin Z, Zang YF, Zeng YW, Zhang L, Wang YF. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study. Neurosci Lett 2001; 315: 45-48.
37. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264.
38. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000; 21: 1645-1649.
39. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B et al. Effects of stimulant medication on growth rates across (3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 2007; 46: 1015-1027.
40. Vermunt JK, Magidson J. LatentGOLD. [3 01]2003. Statistical Innovations, Inc. 2-10-2003.
41. Magidson J, Vermunt JK. Latent class analysis. In: Handbook of quantitative methodology for the social sciences, Kaplan D (ed). Sage Publications: Newbury Park, CA, USA, 2003.
42. Vermunt JK, Magidson J. Latent class cluster analysis. In: Applied latent class analysis, Hagenaars JA & McCutcheon AL (eds) Cambridge University Press, Cambridge, UK, 2002; 89-106.
43. Hagenaars JA. Latent structure models with direct effects between indicators: local dependence models. Sociol Meth Res 1988; 16: 379-405.
44. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-213.
45. Martin ER, Bass MP, Gilbert JR, Pericak-Vance MA, Hauser ER. Genotype-based association test for general pedigrees: the geno-type-PDT. Genet Epidemiol 2003; 25: 203-213.
46. Shapiro MB, Senapathy P. RNA splice junctions of different classes of eukaryotes: sequence statistics functional implications in gene expression. Nucleic Acids Res 1987; 15: 7155-7174.
47. Plessen KJ, Bansal R, Zhu H, Whiteman R, Amat J, Quackenbush GA et al. Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2006; 63: 795-807.
48. Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev 2006; 26: 433-444.
49. Anderson CM, Polcari AM, Lowen SB, Renshaw PF, Teicher MH. Effects of methylphenidate on functional magnetic resonance relaxometry of the cerebellar vermis in children with ADHD. Am J Psychiatry 2002; 159: 1322-1328.
50. Sugita S, Ichtchenko K, Khvotchev M, Sudhof TC. alpha-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors. G-protein coupling not required for triggering exocytosis. J Biol Chem 1998; 273: 32715-32724.
51. Linets'ka MV, Storchak LH, Himmelreich NH. Effect of synapto-somal cytosolic [3H]GABA pool depletion on secretory ability of alpha-latrotoxin]. Ukr Biokhim Zh 2002 74 65-72.
52. Ichtchenko K, Khvotchev M, Kiyatkin N, Simpson L, Sugita S, Sudhof TC. alpha-latrotoxin action probed with recombinant toxin: receptors recruit alpha-latrotoxin but do not transduce an exocytotic signal. EMBO J 1998; 17: 6188-6199.
53. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA et al. Molecular genetics of attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-1323.
54. Tobaben S, Sudhof TC, Stahl B. Genetic analysis of alpha-latrotoxin receptors reveals functional interdependence of CIRL/latrophilin 1 and neurexin 1 alpha. J Biol Chem 2002; 277: 6359-6365.
55. Benichou J. Methods of adjustment for estimating the attributable risk in case-control studies: a review. Stat Med 1991; 10: 1753-1773.
56. Benichou J, Gail MH. Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 1995; 51: 182-194.
57. Spiegelman D, Hertzmark E, Wand HC. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007; 18: 571-579.
58. Hildebrandt M, Bender R, Gehrmann U, Blettner M. Calculating confidence intervals for impact numbers. BMC Med Res Methodol 2006; 6: 32.
59. Ichtchenko K, Bittner MA, Krasnoperov V, Little AR, Chepurny O, Holz RW et al. A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors. J Biol Chem 1999; 274: 5491-5498.